Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MYRIAD GENETICS INCFinancial_Report.xls
10-Q - FORM 10-Q - MYRIAD GENETICS INCd10q.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - MYRIAD GENETICS INCdex312.htm
EX-10.1 - ACCELERATED SHARE REPURCHASE PROGRAM AGREEMENT, DATED MARCH 1, 2011 - MYRIAD GENETICS INCdex101.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - MYRIAD GENETICS INCdex311.htm

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 4, 2011   Date: May 4, 2011
By:    /s/ Peter D. Meldrum   By:    /s/ James S. Evans
Peter D. Meldrum   James S. Evans
President and Chief Executive Officer   Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

1